Stock Analiz

Amphastar Pharmaceuticals, Inc. (AMPH) earnings: date, estimates and history

Price $29.37 · data as of November 13, 2026

Next earnings report

Next reportNot announced yet
Quarterending December 31, 2026
EPS estimate$0.73
Revenue estimate$196M
Expected EPS growth+7.9%

The date appears here once Amphastar Pharmaceuticals confirms it, usually two to four weeks before the report.

Track record

Beat EPS estimates3 of 5
Average surprise+6.5%
Average move on report day±11.5%

Amphastar Pharmaceuticals beat the consensus earnings estimate in 3 of its last 5 reports, by +6.5% on average. On report days the stock moved 11.5% on average, up or down.

Earnings history

ReportedEPS estimateEPS actualSurpriseRevenueRevenue growthStock move
November 5, 2026
Sep/2026
$0.86$1.14+32.8%$208M+8.2%+1.7%
August 6, 2026
Jun/2026
$0.61$0.91+48.3%$184M+5.4%+2.7%
May 7, 2026
Mar/2026
$0.71$0.42−40.5%$171M+0.4%−20.5%
February 26, 2026
Dec/2025
$0.92$0.73−20.5%$183M−1.8%−27.7%
November 6, 2025
Sep/2025
$0.83$0.93+12.7%$192M+0.3%−5.1%

EPS as compared with analyst estimates (adjusted EPS). Revenue growth is against the same quarter a year earlier. Stock move: change on the first trading day after the report.

Frequently asked questions

When is Amphastar Pharmaceuticals’s next earnings date?

Amphastar Pharmaceuticals has not confirmed its next report date yet. Its last report was on November 5, 2026.

Did Amphastar Pharmaceuticals beat earnings last quarter?

Yes, it reported EPS of $1.14 on November 5, 2026 against an estimate of $0.86 (a +32.8% surprise), and the stock moved +1.7% the next trading day.

What EPS do analysts expect next quarter?

The consensus estimate is $0.73 per share on revenue of about $196M.

Report dates and estimates from analyst consensus data; results from company reports. Updated daily. Not investment advice. Earnings calendar